Suto T - Search Results

1

[Factors of gastric lesions following after transcatheter arterial embolization for primary hepatoma].

Ishigaki H, Suto T, Sasaki D, Tsushima K, Higuchi S, Baba T, Sano M, Munakata A, Yoshida Y, Takagi S. Ishigaki H, et al. Among authors: suto t. Nihon Shokakibyo Gakkai Zasshi. 1990 Jan;87(1):57-61. Nihon Shokakibyo Gakkai Zasshi. 1990. PMID: 1691802 Japanese.

2

[A case of acute hepatitis induced by Epstein-Barr virus complicated with disseminated intravascular coagulation].

Soma N, Akiyama M, Suzuki H, Suto T, Sasaki D, Yoshida Y, Ebina T. Soma N, et al. Among authors: suto t. Nihon Shokakibyo Gakkai Zasshi. 1992 Jun;89(6):1386-90. Nihon Shokakibyo Gakkai Zasshi. 1992. PMID: 1323724 Review. Japanese. No abstract available.

3

[A rare case of true enterolith including a fruit seed].

Yamagata K, Niida N, Suto T, Kon K, Nakajima H, Saito H, Munakata A, Yoshida Y, Morita T, Ohkubo F. Yamagata K, et al. Among authors: suto t. Nihon Shokakibyo Gakkai Zasshi. 1995 Apr;92(4):784-8. Nihon Shokakibyo Gakkai Zasshi. 1995. PMID: 7739130 Review. Japanese. No abstract available.

4

Clinical study of biological response modifiers as maintenance therapy for hepatocellular carcinoma.

Suto T, Fukuda S, Moriya N, Watanabe Y, Sasaki D, Yoshida Y, Sakata Y. Suto T, et al. Cancer Chemother Pharmacol. 1994;33 Suppl:S145-8. doi: 10.1007/BF00686688. Cancer Chemother Pharmacol. 1994. PMID: 8137477 Clinical Trial.

5

[A case of nodular transformation of the liver with idiopathic portal hypertension].

Takahata T, Sasaki Y, Hirano K, Ishiguro Y, Takahashi T, Suto K, Suto T, Munakata A, Yodono H, Tanaka M, Kudo H, Kage M. Takahata T, et al. Among authors: suto t, suto k. Nihon Shokakibyo Gakkai Zasshi. 1997 Sep;94(9):615-21. Nihon Shokakibyo Gakkai Zasshi. 1997. PMID: 9311241 Japanese. No abstract available.

6

[A case of chronic pancreatitis with primary biliary cirrhosis whose diameter of pancreatic duct was rapidly changed].

Hanabata N, Tanabe M, Sakamoto J, Suto T, Munakata A, Suto K. Hanabata N, et al. Among authors: suto t, suto k. Nihon Shokakibyo Gakkai Zasshi. 2001 Jan;98(1):58-63. Nihon Shokakibyo Gakkai Zasshi. 2001. PMID: 11201127 Japanese. No abstract available.

7

The effect of YNK-01 (an oral prodrug of cytarabine) on hepatocellular carcinoma.

Suto T, Miyazawa J, Watanabe Y, Suto K, Yoshida Y, Sakata Y. Suto T, et al. Among authors: suto k. Semin Oncol. 1997 Apr;24(2 Suppl 6):S6-122-S6-129. Semin Oncol. 1997. PMID: 9151927 Clinical Trial.

8

[Late phase II study of YNK-01 (an oral prodrug of cytarabine) for hepatocellular carcinoma].

Suto T, Yoshida Y, Sakata Y, Ono T, Yoshida T, Yamada N, Chida N, Oohira H. Suto T, et al. Gan To Kagaku Ryoho. 1998 Oct;25(12):1933-8. Gan To Kagaku Ryoho. 1998. PMID: 9797816 Clinical Trial. Japanese.

9

Clarithromycin-resistance and point mutations in the 23S rRNA gene in Helicobacter pylori isolates from Japan.

Umegaki N, Shimoyama T, Nishiya D, Suto T, Fukuda S, Munakata A. Umegaki N, et al. Among authors: suto t. J Gastroenterol Hepatol. 2000 Aug;15(8):906-9. doi: 10.1046/j.1440-1746.2000.02072.x. J Gastroenterol Hepatol. 2000. PMID: 11022832

10

Influence of hepatic impairment on the pharmacokinetics and pharmacodynamics of landiolol hydrochloride, an ultra-short-acting beta1-blocker.

Takahata T, Yasui-Furukori N, Sakamoto J, Suto K, Suto T, Tateishi T, Munakata A. Takahata T, et al. Among authors: suto t, suto k. Drugs R D. 2005;6(6):385-94. doi: 10.2165/00126839-200506060-00006. Drugs R D. 2005. PMID: 16274261 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

340 results

Search Page

Filters